BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Life Sciences British Columbia - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Life Sciences British Columbia
X-ORIGINAL-URL:https://lifesciencesbc.ca
X-WR-CALDESC:Events for Life Sciences British Columbia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180524
DTEND;VALUE=DATE:20180525
DTSTAMP:20260404T192345
CREATED:20210407T220125Z
LAST-MODIFIED:20210902T211210Z
UID:24287-1527120000-1527206399@lifesciencesbc.ca
SUMMARY:NRC Event: Reimbursement in Europe Workshop
DESCRIPTION:On Thursday\, May 24\, 2018\, LifeSciences BC held its NRC Event: Reimbursement in Europe Workshop. \nWhy Europe? \nEurope represents a highly attractive market for Canadian medical technology manufacturers. With over 500 million people in 28 countries in the European Union alone\, now is the time to take advantage of transparent and reliable reimbursement conditions at the federal level. \nWhy Should You Join?  \nAll European countries have very different reimbursement environments\, health care practices\, sales and distribution options. Choosing the countries that best suit your company and products for initial launch and future sales is crucial as incorrect steps are costly. This interactive full-day workshop was designed to help you understand the various reimbursement schemes in the largest European markets and about first steps towards cost-effective operations in this regard. This seminar focused on Germany and provide additional information on the UK\, France\, Italy and Sweden. \nWho Should Join?  \nCEOs\, CFOs\, VPs Marketing\, Export Managers\, etc.\, who plan to enter the European market or who want some ideas on maximizing sales. \nThe Speaker: \nMichael Weisser\, a research consultant with Assessment in Medicine (AiM GmbH)\, Germany was invited to give you the best know-how to decide which countries are most suited for your business.
URL:https://lifesciencesbc.ca/event/nrc-event-reimbursement-in-europe-workshop/
CATEGORIES:2018
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180523
DTEND;VALUE=DATE:20180524
DTSTAMP:20260404T192345
CREATED:20210407T220553Z
LAST-MODIFIED:20210902T210817Z
UID:24292-1527033600-1527119999@lifesciencesbc.ca
SUMMARY:4th Annual Medical Device Playbook
DESCRIPTION: \n\n\n\nMedical Device Playbook is Canada’s premiere event for medical device professionals. The 4th annual Playbook returned to the Vancouver Terminal City Club on Wednesday\, May 23\, 2018. \nIndustry speakers and panels from British Columbia and across North America discussed what it took to achieve the 2018 theme: Dream a Bigger Dream. \nThis event presented an opportunity to network and learn 2018 trends\, opportunities\, and strategies. Attendees heard Medtech Entrepreneur Case Studies\, Human Factors Insights\, and Clinical/Regulatory advice from industry veterans including: \n\nSTAN LAPIDUS\, Director of numerous public and private medical device and diagnostics companies – Denver\, Founded and led two of the most successful (>$2Bn value) diagnostics companies of all time\nMITCH LEVINSON\, Co-Founder\, President and CEO at Cerebrotech – San Francisco\, CEO/CSO of Coolsculpting system and device\nVIRGINIA A. LANG\, President and Chief Scientist\, HirLan\, Inc. and HirLan International SA – Carlsbad CA\, Human Factors Pioneer\nMIKE TOTTERMAN\, CEO and co-founder of Clerio Vision – Rochester NY\, Co-founded iCardiac Technologies\, and VirtualScopics; former principal at 3Com Ventures\nKEVIN STRANGE\, President and CEO at Biolux Research\, 20 Year veteran of Vancouver Medical Device Start-ups\nMICHAEL HOEY\, Co-Founder & Chief Technology Officer\, NxThera – Minneapolis\, Expert in thermotherapy with 72 patents granted and 94 patents pending \nPAUL WEBER\, President and Chief Executive Officer Perimeter Medical Imaging – Toronto\, Medical Device Marketing\, International Distribution\, and Business Development Expert\nDOUG GOERTZEN\, CEO\, Kardium – Vancouver\, Local SFU EE grad now leading Medtech start-up\nVESNA JANIC\, Director of QA/RA StarFish Medical – Victoria\, QA/RA expert responsible for 30+ concurrent medical devices and client companies\nSCOTT PHILLIPS\, CEO\, StarFish Medical – Victoria\, Creator Medical Device Playbook\nDR. LESLEY ESFORD\, President & CEO\, LifeSciences British Columbia – Vancouver\, Academia\, industry and government leader supporting the growth of the Life Sciences sector\nCHRIS MACDONALD\, Sales Manager\, Canada MHS Business Line\,   TÜV SÜD Canada – Toronto\, Global regulatory compliance expert\nELAYNE WANDLER\, Director\, Programs & Partnerships Accel-Rx – Vancouver\, Health sciences executive and Entrepreneur\nJAMES JACKSON\, Industrial Designer\, StarFish Medical – Victoria\, Designed category-leading products for Logitech\, Olympus\, Medtronic\, Welch Allyn\, Covidien\, and Hollister\n\n\nThis event included Lunch\, Breaks\, and a Networking Reception.\n\n\n\n\n\n\nAGENDA\n\n\n08:00 – 8:50\n\nRegistration\, Coffee/Tea & Networking \n\n08:50 – 9:00\n\nWelcome & Opening Remarks \nSCOTT PHILLIPS\, CEO\, StarFish Medical \n\n9:00 – 10:45\n\nEntrepreneur Presentations \nDOUG GOERTZEN: Kardium – The journey of transforming a naïve idea into a commercial medical device \nSTAN LAPIDUS: Asking Better Questions – how asking new questions leads to the development of large businesses. \nKEVIN STRANGE: My 20 years of Medical Device Start-ups in Vancouver \n\n10:45 – 11:15\n\nCoffee/Tea & Networking \n\n11:15 – 12:30\n\nDesigning Your Company \nMITCH LEVINSON: Cerebrotech: A company “designed” to survive an unforgiving financing environment \nMICHAEL HOEY: Are you limiting your platform’s potential? \n\n12:30 – 13:15\n\nLunch \n\n13:15 – 13:30\n\nAfternoon Welcome & Opening Remarks \nDR.LESLEY ESFORD\, President & CEO\, LifeSciences British Columbia \n\n13:30 – 14:30\n\nPartnering \nMIKE TOTTERMAN: Strategic Partnering to Support Medical Device Development \nPAUL WEBER: Doing strategic partner deals \n\n14:30 – 15:00\n\nHuman Factors \nVIRGINIA A. LANG: Human Factors is good business — not an obstacle! \n\n15:00 – 15:30\n\nCoffee/Tea & Networking \n\n15:30 – 16:30\n\nClinical/Regulatory \nVESNA JANIC: Preparing for ISO 13485:2016 \nCHRIS MACDONALD: Do’s and Don’ts of Medical Electrical device certification and testing \nJAMES JACKSON: Are you designing for the correct guidance regulations? \n\n16:30 – 16:50\n\nChanging Perspectives \nSCOTT PHILLIPS: Dream a Bigger Dream \n\n16:50 – 17:00\n\nClosing Remarks \nSCOTT PHILLIPS: Closing Remarks \n\n17:00 – 18:00\n\nNetworking Reception \nELAYNE WANDLER: Reception Welcome \nReception sponsored by Accel-Rx Health Sciences Accelerator \n\n\n\n\nAll net proceeds went to LifeSciences BC for future MedTech initiatives.
URL:https://lifesciencesbc.ca/event/4th-annual-medical-device-playbook/
CATEGORIES:2018
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180510
DTEND;VALUE=DATE:20180511
DTSTAMP:20260404T192345
CREATED:20210407T220728Z
LAST-MODIFIED:20211018T225401Z
UID:24294-1525910400-1525996799@lifesciencesbc.ca
SUMMARY:IP Protection for the Cannabis Industry
DESCRIPTION:Using IP to Protect Medical Applications of Cannabis:  Tips and Strategies for Innovators\nWith the impending legalization of recreational cannabis\, there is tremendous interest in a plant that has long lurked in the shadows of illegality. There is also significant interest in the medicinal qualities of cannabis and some of its key components\, which are useful in managing chronic pain and show promise in the treatment of numerous disorders.  With such unexplored ground comes the potential to develop new innovations\, and a need to protect those innovations in the best way possible. \nThere are a number of ways that intellectual property (IP) can be used to protect cannabis-related innovations. On Thursday\, May 10\, 2018\, LifeSciences BC held its IP Protection for the Cannabis Industry session\, which outlined how IP can be applied to help businesses secure the value of new innovations relating to medical applications of cannabis. Specific examples of medical applications of cannabis or cannabinoids that have been patented or are the subject of pending patent applications were given and compared to contrasting examples of situations where trade secret protection might be considered over patent protection. Different strategies for protecting new strains of cannabis were discussed\, as well as the interplay between plant breeders’ rights and trademark rights when the names of new strains are to be protected. \nThis session was of interest to those concerned with IP strategy for companies investigating new medical applications of cannabis or new cannabis strains\, as well as to investors looking to ensure that their investments in this sector will be protected. This session also offered those who are interested in the cannabis industry generally an opportunity to learn more about some of the unique considerations that apply to using IP to protect cannabis-related innovations. \nSpeakers:\nJennifer Marles: partner and intellectual property lawyer with Oyen Wiggs \nGina Lupino: registered US Patent Attorney \n\nLana Culley: Director of Business Development\, Anandia Labs \n\nEvent sponsor:
URL:https://lifesciencesbc.ca/event/ip-protection-for-the-cannabis-industry/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/ipprotection2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180508
DTEND;VALUE=DATE:20180509
DTSTAMP:20260404T192345
CREATED:20210407T220858Z
LAST-MODIFIED:20210902T205422Z
UID:24296-1525737600-1525823999@lifesciencesbc.ca
SUMMARY:MedTech Showcase Series: Clarius Mobile Health
DESCRIPTION:On Tuesday\, May 8\, 2018\, LifeSciences BC held its Medtech Showcase Series: Clarius Mobile Health event. Founded by ultrasound innovators\, Clarius Mobile Health aims to make ultrasound available to all clinicians. Clarius Mobile’s high-resolution\, affordable handheld ultrasound scanners offer clinicians the freedom to use ultrasound anywhere they need it. Clarius Scanners are regulatory cleared for sale in more than 20 countries worldwide. For more information\, visit www.clarius.com. \nSpeakers:  \nLaurent Pelissier\, CEO\, Clarius Mobile Health \nKris Dickie\, VP of R&D\, Clarius Mobile Health
URL:https://lifesciencesbc.ca/event/medtech-showcase-series-clarius-mobile-health/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/medtech2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180419
DTEND;VALUE=DATE:20180420
DTSTAMP:20260404T192345
CREATED:20210407T221717Z
LAST-MODIFIED:20210927T190050Z
UID:24300-1524096000-1524182399@lifesciencesbc.ca
SUMMARY:20th Annual LifeSciences BC Awards Dinner\, presented by FARRIS
DESCRIPTION:20th Annual LifeSciences BC Awards\npresented by\n\nThursday\, April 19\, 2018\nFairmont Hotel Vancouver\nEvent Photos \nKEYNOTE ADDRESS\nHon. Bruce Ralston \nMinister\, Jobs\, Trade and Technology \nThe 2018 LifeSciences BC Award Winners\nGenome BC Award for Scientific Excellence \nDr. Sally Aitken\n\nMichael Smith Foundation for Health Research \nAubrey J. Tingle Award\nDr. David Huntsman\n\nMilton Wong Award for Leadership\nDr. Michael Abrams\n\nGrowth Stage Life Sciences Company of Year\nAbCellera Biologics Inc.\n\nStrategic Life Sciences Partner of the Year Award\nStarFish Medical Inc.\n\nMedtech Company of the Year\nRedlen Technologies Inc.\n\nGrowth Stage Medtech Company of the Year\nbioLytical Laboratories Inc.\n\nDeal of the Year Award\nZymeworks Inc.\n \nLifeSciences Company of the Year\nAurinia Pharmaceuticals Inc.\n\nDr. Don Rix Award for Lifetime Achievement\nDrs. Connie & Allen Eaves\nPresented by: \n  \nFarris LLP \n  \nAward Sponsors:  \n\n\n\n\n\n \n\n\n \n \n \n\n\n \n \n\n\n\n\nBook your one night stay at the Fairmont Hotel Vancouver! \n 
URL:https://lifesciencesbc.ca/event/20th-annual-lifesciences-bc-awards-dinner-presented-by-farris/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/farrisawards2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180328
DTEND;VALUE=DATE:20180329
DTSTAMP:20260404T192345
CREATED:20210407T222316Z
LAST-MODIFIED:20210902T204753Z
UID:24307-1522195200-1522281599@lifesciencesbc.ca
SUMMARY:MedTech Showcase Series: LightIntegra Technology
DESCRIPTION:LightIntegra’s first product\, ThromboLUX\, was introduced to the US market in late 2017 and is starting to make a splash – by using ThromboLUX to determine platelet activation status\, hospitals are seeing unprecedented reductions in platelet use for blood cancer treatment. On Wednesday\, March 28\, 2018\, LifeSciences BC held its MedTech Showcase Series: LightIntegra Technology where attendees learned more about how ThromboLUX helps hospitals allocate platelets for more effective use\, and heard about its other applications in transfusion medicine and diagnostics.
URL:https://lifesciencesbc.ca/event/medtech-showcase-series-lightintegra-technology/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/medtechlightintegra.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180307
DTEND;VALUE=DATE:20180308
DTSTAMP:20260404T192345
CREATED:20210407T222732Z
LAST-MODIFIED:20210914T163410Z
UID:24310-1520380800-1520467199@lifesciencesbc.ca
SUMMARY:LifeSciences BC Showcase Series: Victoria
DESCRIPTION:On Wednesday\, March 7\, 2018\, LifeSciences BC presented a unique opportunity to learn more about LifeSciences BC along with the cutting-edge research and development being done in the Victoria area. The event was a networking opportunity for a wide range of guests from the political\, business and academic worlds. \nSpeakers:\nDr. Lesley Esford\, President & CEO\nLifeSciences BC\n \nGlenn Bindley\, President & CEO\nRedlen Technologies\n \nDr. Brian Christie\, Professor of medicine and neuroscience\nUniversity of Victoria Island Medical Program\n2007 Michael Smith Foundation for Health Research Scholar\n \nDr. David Llewellyn\, Sr. Vice President\, Business Operations\nSTEMCELL Technologies\n\n\nDr. Brad Nelson\, Distinguished Scientist and Director\, Deeley Research Centre\, Co-Director\, Immunotherapy Program\nBC Cancer Agency\n\nThank you to: \nEvent Sponsor: \n \n  \nSpeaker Sponsor: \n \nSpeaker Sponsor:
URL:https://lifesciencesbc.ca/event/lifesciences-bc-showcase-series-victoria/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/victoria2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180306
DTEND;VALUE=DATE:20180307
DTSTAMP:20260404T192345
CREATED:20210407T222900Z
LAST-MODIFIED:20210914T162922Z
UID:24314-1520294400-1520380799@lifesciencesbc.ca
SUMMARY:LifeSciences BC Blakes Breakfast Speaking Event
DESCRIPTION:This Breakfast Speaking Series is proudly presented by: \n \nOn Tuesday\, March 6\, 2018\, LifeSciences BC held a Blakes Breakfast Speaking Event. \nThe Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. Held four times a year\, these breakfasts include presentations by local\, national and multinational life science companies and typically attract a cross-section of approximately 40 of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \nKeynote speaker: \nDr. Arpita Maiti\, Senior Director\, External Science & Innovation (ES&I)\, Inflammation & Immunology and Microbiome at Pfizer Boston \nSpeakers: \nDr. Rob Fraser\, CEO at Molecular You \nMalcolm Kendall\, CEO at Microbiome Insights \nSacha Mann\, President at BioSys
URL:https://lifesciencesbc.ca/event/lifesciences-bc-blakes-breakfast-speaking-event-5/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/03/fallnetworkingevent-1.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180222
DTEND;VALUE=DATE:20180223
DTSTAMP:20260404T192345
CREATED:20210407T223052Z
LAST-MODIFIED:20210903T213559Z
UID:24316-1519257600-1519343999@lifesciencesbc.ca
SUMMARY:LifeSciences BC McCarthy Spotlight Speaking Series
DESCRIPTION:This Spotlight Speaking Series was proudly presented by: \n \nOn Thursday\, February 22\, 2018\, LifeSciences BC held the spring McCarthy Spotlight Speaking Event. \nEvent topic: Strategic Partnerships\, Accelerating Innovation \nOur McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year\, these events start with presentations on specific topics by local representatives of LifeSciences BC members. Typically\, the event is attended by a cross-section of approximately 40 of our life sciences community members representing mainly industry\, NPOs\, and Government. \nIn the past\, the series has featured topics focusing on attracting and keeping good talent\, technology and licensing\, M&A and Capital Markets\, to name a few. \nSpeakers:  \nPaul Kang\, Chief Scientific Officer at Innovative Targeting Solutions \nTamer Mohamed\, CEO at Aspect Biosystems \nDavid Poon\, Executive Director of External R&D and Alliances at Zymeworks
URL:https://lifesciencesbc.ca/event/lifesciences-bc-mccarthy-spotlight-speaking-series/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/mccarthy2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180117
DTEND;VALUE=DATE:20180119
DTSTAMP:20260404T192345
CREATED:20210407T223304Z
LAST-MODIFIED:20211108T222753Z
UID:24319-1516147200-1516319999@lifesciencesbc.ca
SUMMARY:2018 Access to Innovation
DESCRIPTION:On Wednesday\, January 17 and Thursday\, January 18\, 2018\, LifeSciences BC held the 2018 Access to Innovation event. \n2018 ACCESS TO INNOVATION\nThank you to our event supporters! \nBDC Capital joined as co-presenter this year\, following on the success of the first-ever Canadian Corporate Innovation Summit.\nSpeaker Bios: \n2018 Access to Innovation Speakers – Day 1\n2018 Access to Innovation Speakers – Day 2\nDeloitte Conference Materials:\nDeloitte-uk-life-sciences-health-care-predictions-2022 Western Canada Edition \n \nConfirmed Speakers:\n\n\nOhad Arazi: Vice President & General Manager\, TELUS Health Living Labs\nDr. Cedric Bisson: Partner\, Teralys Capital\nEla Borenstein\, Program Director\, BDC Capital\n\n\nVern Brownell: CEO\, D-Wave Systems\nDr. Pieter Cullis\, Director\, NanoMedicines Research Group; Professor\, Department of Biochemistry and Molecular Biology\n\nDr. Elai Davicioni: President & Chief Scientific Officer\, GenomeDX Biosciences\nKarimah Es Sabar: CEO & Partner\, Quark Venture Inc and the Director of the Global Health Sciences Fund\nPamela Fralick: President\, Innovative Medicines Canada\n\nDr. Mark Gelfer: Chairman\, GenXys Health Care Systems Inc.\n\nDr. Tom Hawes: Managing Director\, BlueCross BlueShield Venture Fund\nPeter Jones: Industry Lead – Healthcare\, Microsoft Canada\nDr. Steven Jones\, Associate Director and Head\, Bioinformatics\, Genome Sciences Centre\, Vancouver\nDr. Dermot Kelleher\, Dean\, Faculty of Medicine\, University of British Columbia\nErik Kiss: CEO\, Imaging Reality\nDion Madsen\, Senior Managing Partner\, Healthcare Fund\, BDC Venture Capital\nDr. Steve Mathias: Clinical Assistant Professor\, UBC\nDavid McGovern: Associate Deputy Minister\, Innovation\, Science and Economic Development Canada\nDr. Joby McKenzie: Senior Vice President Business Development\, LifeLabs\nDr. Peter McWilliams: Managing Director\, Sanderling Ventures\nFazil Mihlar: Deputy Minister\, Ministry of Jobs\, Trade & Technology\, Government of British Columbia\nDr. Gail Murphy\, Vice-President Research & Innovation\, UBC\nSue Paish: Healthcare Leader\nDr. Jeff Pike: Clinical Transformation Lead\, Providence Health Care\nDr. Simon Pimstone: President & CEO\, Xenon Pharmaceuticals\, Founder\, SAVE BC\nDr. Mohammed Qadir: President & Chief Scientific Officer\, Fusion Genomics Corporation\nDr. Alan Rabinowitz: Co-Founder\, Chief Medical Officer & a Director PHEMI Health Systems\nDr. Rachael Ritchie: Vice President\, Strategy and Partnerships\, The Centre for Drug Research & Development\nRobert Scully: Director\, Manulife Capital Ventures\nMike Standing\, Leader Life Sciences and Health Care EMEA Region\, Deloitte\nDr. Lesley Stolz: Head\, JLABS California\nBill Tam: Interim Co-Chair\, Canada’s Digital Technology Supercluster\nKaren Wichuk: Executive Lead\, Health City Edmonton\nDr. Peter Zandstra\, Director\, School of Biomedical Engineering\, UBC\, Director\, Michael Smith Laboratories\, UBC\n\nDr. Steven Xanthoudakis: Chief Business Development Officer\, CQDM Quebec Consortium for Drug Discovery\n\n\nConference Partner: \nLuncheon Sponsors: GSK \nPresenting Afternoon Sponsor: \nSession Sponsors:  \nReception Sponsor: \nBreakfast & Morning Refreshment Sponsor:  \nGeneral Supporter: GenomeBC
URL:https://lifesciencesbc.ca/event/2018-access-to-innovation/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/accesstoinnovation2018.jpg
END:VEVENT
END:VCALENDAR